"Rapid and poorly managed weight loss can have visible aesthetic consequences for both the face and the body," warns Dr Beatriz Beltrn, an aesthetic doctor who has already treated over 1,000 patients for this issue
Several additional THR agonists are undergoing clinical evaluation, including ASC41 (phase II, China) (163, 164), HSK31679 (early study) (162), TERN-501 (165) (phase IIa), Sobetirome (GC-1, half before phase II) (164, 166), Eprotirome, Sobetirome, exhibited lipid-lowering effects in phase I trials under both single and multiple dosing regimens
Alan Landay at the University of Texas Medical Branch
The coverage you select today will be there for you tomorrow, next year, and for years to come regardless of how your health might change